A 62-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent for a non-ACS lesion. Which antiplatelet duration is most ...

Question

A 62-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent for a non-ACS lesion. Which antiplatelet duration is most appropriate absent high bleeding risk?

Accepted Answer

Dual antiplatelet therapy for 6 months then aspirin alone

Answer

Aspirin alone from discharge

Answer

Dual antiplatelet therapy for 1 month

Answer

Dual antiplatelet therapy for 3 months then stop both

Answer

Dual antiplatelet therapy for 12 months then stop all

us-usmle-step-2 MCQ (SBA): Post-PCI Antiplatelet Therapy

A 62-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent for a non-ACS lesion. Which antiplatelet duration is most appropriate absent high bleeding risk?